Lionel Uwer

1.7k total citations
14 papers, 189 citations indexed

About

Lionel Uwer is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Lionel Uwer has authored 14 papers receiving a total of 189 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Cancer Research. Recurrent topics in Lionel Uwer's work include Advanced Breast Cancer Therapies (6 papers), Breast Cancer Treatment Studies (5 papers) and Cancer Treatment and Pharmacology (4 papers). Lionel Uwer is often cited by papers focused on Advanced Breast Cancer Therapies (6 papers), Breast Cancer Treatment Studies (5 papers) and Cancer Treatment and Pharmacology (4 papers). Lionel Uwer collaborates with scholars based in France and Switzerland. Lionel Uwer's co-authors include Thierry Conroy, Marie‐Christine Kaminsky, Françis Guillemin, L. Tournier-Rangeard, I. Léonard, Mariette Mercier, Philippe Rauch, Philippe Montcuquet, Christine Rotonda and Étienne Brain and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and British Journal of Cancer.

In The Last Decade

Lionel Uwer

13 papers receiving 187 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lionel Uwer France 6 140 56 38 29 21 14 189
Gustav Magrinat United States 7 120 0.9× 54 1.0× 54 1.4× 12 0.4× 13 0.6× 10 184
Aude Bardot France 8 140 1.0× 49 0.9× 47 1.2× 37 1.3× 24 1.1× 17 253
Gilles Freyer France 8 167 1.2× 39 0.7× 24 0.6× 24 0.8× 8 0.4× 21 248
Anna Rachelle Mislang Australia 11 130 0.9× 62 1.1× 28 0.7× 32 1.1× 31 1.5× 26 298
Sujay Srinivas India 9 122 0.9× 80 1.4× 20 0.5× 58 2.0× 27 1.3× 36 251
Lotte Holm Land Denmark 5 202 1.4× 53 0.9× 99 2.6× 29 1.0× 25 1.2× 11 301
Jeffrey T. Yorio United States 8 193 1.4× 136 2.4× 50 1.3× 70 2.4× 22 1.0× 22 323
Mohamed Ramdani France 6 123 0.9× 78 1.4× 26 0.7× 49 1.7× 24 1.1× 10 299
Vikas Talreja India 9 121 0.9× 151 2.7× 39 1.0× 59 2.0× 14 0.7× 29 279
Sushmita Rath India 8 83 0.6× 40 0.7× 20 0.5× 33 1.1× 12 0.6× 25 143

Countries citing papers authored by Lionel Uwer

Since Specialization
Citations

This map shows the geographic impact of Lionel Uwer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lionel Uwer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lionel Uwer more than expected).

Fields of papers citing papers by Lionel Uwer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lionel Uwer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lionel Uwer. The network helps show where Lionel Uwer may publish in the future.

Co-authorship network of co-authors of Lionel Uwer

This figure shows the co-authorship network connecting the top 25 collaborators of Lionel Uwer. A scholar is included among the top collaborators of Lionel Uwer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lionel Uwer. Lionel Uwer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Lusque, Amélie, Audrey Mailliez, Thomas Bachelot, et al.. (2022). Comparison of Management and Outcomes in ERBB2-Low vs ERBB2-Zero Metastatic Breast Cancer in France. JAMA Network Open. 5(9). e2231170–e2231170. 25 indexed citations
2.
Jacot, William, Amélie Lusque, Cécile Vicier, et al.. (2022). Outcomes of patients with HER2-negative metastatic breast cancer after platinum- and non-platinum-based first-line chemotherapy among patients with and without pathogenic germline BRCA1/2 mutations. British Journal of Cancer. 127(11). 1963–1973. 3 indexed citations
3.
Uwer, Lionel, Véronique Lorgis, Audrey Hennequin, et al.. (2022). Optimization of G-CSF dosing schedule in patients treated with eribulin: a modeling approach. Cancer Chemotherapy and Pharmacology. 89(2). 197–208. 1 indexed citations
4.
Herbreteau, Guillaume, Alexandra Langlais, Laurent Greillier, et al.. (2020). Circulating Tumor DNA as a Prognostic Determinant in Small Cell Lung Cancer Patients Receiving Atezolizumab. Journal of Clinical Medicine. 9(12). 3861–3861. 31 indexed citations
5.
Lovinfosse, Pierre, Caroline Rousseau, Jean‐Yves Pierga, et al.. (2019). Dual time point [18F]FLT-PET for differentiating proliferating tissues vs non-proliferating tissues. EJNMMI Research. 9(1). 109–109. 2 indexed citations
6.
Jacquin, Jean-Philippe, Lionel Uwer, Alexia Savignoni, et al.. (2019). Safety profile of subcutaneous trastuzumab in patients with HER2-positive early breast cancer: The French HERmione non-interventional prospective study. The Breast. 49. 1–7. 5 indexed citations
7.
Uwer, Lionel, Julia Salleron, María Rios, et al.. (2019). Abstract OT1-03-02: CICLADES: Monitoring of ESR1, PIK3CA and AKT1 ctDNA mutations during real-life follow-up of patients with advanced breast cancer treated with endocrine therapy. Cancer Research. 79(4_Supplement). OT1–3. 1 indexed citations
8.
Saux, Olivia Le, Audrey Lardy-Cléaud, Paul Cottu, et al.. (2017). Assessment of multiple endocrine therapies for metastatic breast cancer in a multicenter national observational study.. Journal of Clinical Oncology. 35(15_suppl). 1052–1052. 2 indexed citations
9.
Cottu, Paul, Audrey Lardy-Cléaud, Olivia Le Saux, et al.. (2017). Use of everolimus in advanced hormone receptor–positive metastatic breast cancer in a multicenter national observational study.. Journal of Clinical Oncology. 35(15_suppl). e12548–e12548.
10.
Delaloge, Suzette, David Pérol, Étienne Brain, et al.. (2016). Overall survival of patients with HER2-negative metastatic breast cancer treated with a first-line paclitaxel with or without bevacizumab in real-life setting: Results of a multicenter national observational study.. Journal of Clinical Oncology. 34(15_suppl). 1013–1013. 4 indexed citations
11.
Uwer, Lionel, Christine Rotonda, Françis Guillemin, et al.. (2011). Responsiveness of EORTC QLQ-C30, QLQ-CR38 and FACT-C quality of life questionnaires in patients with colorectal cancer. Health and Quality of Life Outcomes. 9(1). 70–70. 62 indexed citations
12.
Brain, Étienne, C. Mertens, Véronique Girre, et al.. (2010). Impact of liposomal doxorubicin-based adjuvant chemotherapy on autonomy in women over 70 with hormone-receptor-negative breast carcinoma: A French Geriatric Oncology Group (GERICO) phase II multicentre trial. Critical Reviews in Oncology/Hematology. 80(1). 160–170. 38 indexed citations
13.
Conroy, Thierry, et al.. (2007). Health-related quality-of-life assessment in gastrointestinal cancer: are results relevant for clinical practice?. Current Opinion in Oncology. 19(4). 401–406. 10 indexed citations
14.
Uwer, Lionel, Danièle Sommelet, Daniel Molé, et al.. (2003). [How to improve the initial management of adult patients with tumors of bone and soft tissues: the experience of a multidisciplinary committee from the Oncolor network before the distribution of regional guidelines].. PubMed. 90(3). 269–77. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026